Literature DB >> 10705298

Interleukin-18 stimulates HIV-1 replication in a T-cell line.

S A Klein1, C Klebba, D Kauschat, M Pape, L Ozmen, D Hoelzer, O G Ottmann, U Kalina.   

Abstract

Interleukin-18 (IL-18) is a recently identified proinflammatory cytokine. Its ability to induce interferon-g suggests a potential virustatic effect. On the other hand, it stimulates NFkB - an activator of HIV replication. Recently, stimulation of HIV-1 in monocytic cells has been demonstrated. In the present study, the influence of IL-18 on HIV-1 replication in lymphatic cells was investigated. Hut78 cells were infected with HIV-1 in the presence of recombinant human IL-18 expressed either in E. coli or eucaryotically by baculovirus in Sf9 cells. HIV-1 replication was monitored by p24 ELISA and endpoint titration of culture supernatants on C8166 cells. The addition of IL-18 led to a 3- to 15-fold enhancement of HIV replication in Hut78 cells. By addition of neutralising monoclonal anti-IL-18 antibodies, this effect of IL-18 was reduced by 75%. Exposure of Hut78 to IL-18 prior to HIV infection could exclude the possibility that IL-18 promotes infection of cells. Taken together, these data provide direct evidence for an IL-18-mediated enhancement of HIV-1 replication in lymphatic cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10705298

Source DB:  PubMed          Journal:  Eur Cytokine Netw        ISSN: 1148-5493            Impact factor:   2.737


  11 in total

Review 1.  The CD8+ T Cell Noncytotoxic Antiviral Responses.

Authors:  Maelig G Morvan; Fernando C Teque; Christopher P Locher; Jay A Levy
Journal:  Microbiol Mol Biol Rev       Date:  2021-05-12       Impact factor: 11.056

2.  IL-18 gene promoter polymorphism is involved in HIV-1 infection in a Brazilian pediatric population.

Authors:  Ludovica Segat; Daiana Bevilacqua; Michele Boniotto; Luiz C Arraes; Paulo R de Souza; Josè L de Lima Filho; Sergio Crovella
Journal:  Immunogenetics       Date:  2006-05-05       Impact factor: 2.846

Review 3.  Innate and adaptive factors regulating human immunodeficiency virus type 1 genomic activation.

Authors:  Sonia Shah; Michael R Nonnemacher; Vanessa Pirrone; Brian Wigdahl
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-13       Impact factor: 4.147

4.  Serum and cerebrospinal fluid levels of interleukin-18 in human immunodeficiency virus type 1-associated central nervous system disease.

Authors:  Hans-Jürgen von Giesen; Sebastian Jander; Hubertus Köller; Gabriele Arendt
Journal:  J Neurovirol       Date:  2004-12       Impact factor: 2.643

5.  Elevated levels of circulating interleukin-18 in human immunodeficiency virus-infected individuals: role of peripheral blood mononuclear cells and implications for AIDS pathogenesis.

Authors:  Rasheed Ahmad; Sardar T A Sindhu; Emil Toma; Richard Morisset; Ali Ahmad
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

Review 6.  The role of cytokines in the establishment, persistence and eradication of the HIV reservoir.

Authors:  Claire Vandergeeten; Rémi Fromentin; Nicolas Chomont
Journal:  Cytokine Growth Factor Rev       Date:  2012-06-27       Impact factor: 7.638

7.  Raised serum levels of interleukin-18 is associated with disease progression and may contribute to virological treatment failure in HIV-1-infected patients.

Authors:  E Stylianou; V Bjerkeli; A Yndestad; L Heggelund; T Waehre; J K Damås; P Aukrust; S S Frøland
Journal:  Clin Exp Immunol       Date:  2003-06       Impact factor: 4.330

8.  Interleukin-18 is regulated by G protein pathways and protein kinase signals in human fibroblasts.

Authors:  Marc K Schuler; Wilhelm K Aicher
Journal:  Rheumatol Int       Date:  2003-07-15       Impact factor: 2.631

9.  Interleukin 18 and human immunodeficiency virus type I infection in adolescents and adults.

Authors:  W Song; C M Wilson; S Allen; C Wang; Y Li; R A Kaslow; J Tang
Journal:  Clin Exp Immunol       Date:  2006-04       Impact factor: 4.330

10.  IL-18 Gene Promoter Region 607C/A Polymorphism in HIV-1 Infected North Indian Population.

Authors:  Rc Sobti; Vl Sharma; Am Abitew; N Berhane; Sa Mahdi; M Askari; Vs Kuttiat; A Wanchu
Journal:  Balkan J Med Genet       Date:  2011-12       Impact factor: 0.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.